Status:
RECRUITING
Hyaluronic Acid-enriched Transfer Medium in Single Blastocyst Transfer
Lead Sponsor:
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Collaborating Sponsors:
Jiangxi Maternal and Child Health Hospital
Gansu Provincial Maternal and Child Health Care Hospital
Conditions:
Infertility
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to compare the live birth rates of high concentration of Hyaluronic Acid (0.5 mg/ml) transfer medium (EmbryoGlue®) to those containing low Hyaluronic Acid concentrations (...
Detailed Description
The single blastocyst-stage embryo transfer cycles will be randomised in a 1:1 allocation, with block sizes of 2 and 4 on the day of Embryo Transfer (ET). This randomisation process will be centrally ...
Eligibility Criteria
Inclusion
- All cycles with single blastocyst transfer will be considered eligible
- Both fresh and cryopreserved embryo transfer cycles utilizing autologous oocytes
- No age restriction will be applied
- Informed consent was signed
Exclusion
- Uterine anatomic anomalies
- Women with untreated hydrosalpines
- Once couples have been enrolled in the trial, subsequent cycles will not be incorporated.
Key Trial Info
Start Date :
September 13 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
858 Patients enrolled
Trial Details
Trial ID
NCT06492785
Start Date
September 13 2024
End Date
December 31 2025
Last Update
December 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
IVF laboratory
Xi'an, Shaanxi, China, 710003